More study needed on vitamin D-ovarian cancer link

	Tweet

There isn’t enough evidence to back or debunk the claim that vitamin D can help reduce the risk of ovarian cancer, despite several recent studies making this claim, the authors of a new review of the scientific literature conclude.

“Based on the current evidence, it is premature to make any definitive claims for or against the role of vitamin D in ovarian cancer,” Dr. Dr. Linda S. Cook of the University of New Mexico in Albuquerque and her colleagues conclude.

Nevertheless, they add, because an association between vitamin D and the disease is “biologically plausible,” and there were problems with the studies that they reviewed, “this is an area worthy of further primary research.”

Several review articles—evaluations of original research on a particular topic—have reported that vitamin D guards against ovarian cancer or the risk of dying from the disease, Cook and her team note in the American Journal of Obstetrics & Gynecology.

To investigate the quality of the evidence for this claim, they searched the medical literature and identified 20 studies for review. Ten were ecological studies, meaning they used an environmental measure of vitamin D levels, such as latitude (sun exposure is higher the closer one is to the equator) or direct measurements of ultraviolet light exposure; six were case-control studies, comparing vitamin D exposure in people with ovarian cancer and people without the disease; and four were cohort studies, in which a group of people were followed over time and their risk of developing ovarian cancer was compared to their vitamin D exposure.

The researchers identified several flaws in the studies, including women having low vitamin D intakes that often didn’t reach recommended daily amounts for the nutrient, and the use of “food frequency” questionnaires to measure vitamin D intake, a “less than optimal” strategy.

The best evidence, they say, came from a study in which investigators tested the levels of vitamin D in women’s blood before they were diagnosed with ovarian cancer. This study found no evidence for an overall association between vitamin D levels and risk of the disease, although overweight women did have a lower risk of the disease as their vitamin D levels increased - “a finding that needs to be confirmed in other studies,” the researchers say.

“A simple increase in vitamin D exposure, if truly associated with lowered risk, would be an important intervention strategy for reducing ovarian cancer occurrence,” Cook and her colleagues conclude. “This hypothesis, however, needs to be tested with rigorous epidemiologic studies.”

SOURCE: American Journal of Obstetrics & Gynecology, March 2010.

RELATED STORIES:
‘Clumping’ Protein Linked to Return of Ovarian Cancer   Ovarian Cancer Screening Not Catching Early Disease   Possible New Therapy for Patients with Platinum-Resistant Ovarian Cancer   Faulty proteins may prove significant in identifying new treatments for ovarian cancer   Ovarian Cancer Study Gets Aid   FDA clears biomarker test for ovarian cancer   Angiogenesis Linked to Poor Survival in Patients with Rare Type of Ovarian Cancer   Why are African Americans less Likely to Survive Certain Cancers?   Ovarian cancer risk not affected by alcohol and smoking, but reduced by caffeine   Blood test detects ovarian cancer early   Birth control pill lowers ovarian cancer risk - study   Vascular marker of ovarian cancer identified   Proteins show promise for ovarian cancer screening   Birth after cancer treatment with removal and storage of ovary   Dietary factors influence ovarian cancer survival rates   St. John’s wort and polymeric nanoparticles to treat ovarian tumors using light   New treatment to overpower drug resistance in ovarian cancer   Two gene mutations mark deadly ovarian cancer   Ginkgo may ward off ovarian cancer   Study Finds Aspirin, Vitamin E Don’t Prevent Cancer   Ovarian cancer screening popular despite guidelines   Tiny genetic variation can predict ovarian cancer outcome

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]